Research programme: anti-cancer antibody - BioMed Valley DiscoveriesAlternative Names: BVD TEM8; BVD-AB1
Latest Information Update: 25 Feb 2016
At a glance
- Originator BioMed Valley Discoveries
- Class Antibodies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 25 Feb 2016 Preclinical trials in Cancer in USA (Parenteral) before February 2016
- 15 Feb 2013 Early research in Cancer in USA (Parenteral)